Recruiting NCT07228871
The Effectiveness of Transcranial Magnetic Stimulation and Mirror Therapy in Hemispatial Neglect
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Mirror Therapy, cTBS, Cognitive rehabilitation.
- Who it may be relevant to
- Registry conditions: Hemispatial Neglect. Basic parameters: 18 years — 75 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Turkey (Türkiye)
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Evaluation of the Effectiveness of Transcranial Magnetic Stimulation and Mirror Therapy in Hemispatial Neglect Developing After Stroke
Overview
The aim of this study is to evaluate the effectiveness of continuous Theta Burst Stimulation added to mirror therapy on neglect associated with stroke.
Interventions
- Other Mirror Therapy
Mirror therapy will be administered 5 days a week for 2 weeks. - Device cTBS
Patients received cTBS applied to the P3 region according to the 10/20 electroencephalogram system for 5 days a week, totalling 10 sessions over 2 weeks. - Other Cognitive rehabilitation
Methods that facilitate adaptation in daily life activities will be taught.
Primary outcome measures
- Catherine Bergego Scale [Time frame: Before Treatment and 2nd week of treatment]
Secondary outcome measures (3)
- Verbal and Nonverbal Cancellation Test [Time frame: Before Treatment and 2nd week of treatment]
- Line Bisection Test [Time frame: Before Treatment and 2nd week of treatment]
- Barthel Index [Time frame: Before Treatment and 2nd week of treatment]
Eligibility criteria
Inclusion criteria
- Ischemic/haemorrhagic stroke
- Right hemisphere lesion
- Patients with a duration of more than 7 days but less than 1 year from the date of the event
- Aged between 18 and 75 years
- Patients with a Mini Mental Test Score ≥ 24
Exclusion criteria
- History of recurrent stroke
- Presence of vision or hearing problems
- Use of medication affecting cognitive function
- History of epilepsy
- Pregnancy or breastfeeding
- History of malignancy
- Pacemaker
- Presence of metallic implants in the brain or scalp (including cochlear implant)
- History of premorbid dementia
- Presence of psychiatric or additional neurological disease
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Treatment
Study locations
Turkey (Türkiye) · 1 center
- Ankara Etlik City Hospital — Ankara
Identifiers
NCT: NCT07228871 · AEŞH-EK-2025-164